Searle & Co’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-21,350
| Closed | -$2.47M | – | 166 |
|
|
2023
Q3 | $2.47M | Hold |
21,350
| – | – | 0.84% | 31 |
|
|
2023
Q2 | $2.14M | Sell |
21,350
-894
| -4% | -$89.6K | 0.66% | 45 |
|
|
2023
Q1 | $2.47M | Sell |
22,244
-1,106
| -5% | -$123K | 0.81% | 37 |
|
|
2022
Q4 | $2.66M | Hold |
23,350
| – | – | 0.91% | 33 |
|
|
2022
Q3 | $1.45M | Sell |
23,350
-150
| -0.6% | -$9.28K | 0.56% | 52 |
|
|
2022
Q2 | $1.87M | Buy |
23,500
+1,000
| +4% | +$79.7K | 0.74% | 44 |
|
|
2022
Q1 | $2.37M | Hold |
22,500
| – | – | 0.87% | 39 |
|
|
2021
Q4 | $2.43M | Hold |
22,500
| – | – | 0.88% | 39 |
|
|
2021
Q3 | $2.47M | Hold |
22,500
| – | – | 1.01% | 36 |
|
|
2021
Q2 | $2.11M | Hold |
22,500
| – | – | 0.86% | 44 |
|
|
2021
Q1 | $2.07M | Sell |
22,500
-750
| -3% | -$69K | 0.92% | 40 |
|
|
2020
Q4 | $1.7M | Buy |
23,250
+10,500
| +82% | +$768K | 0.82% | 47 |
|
|
2020
Q3 | $990K | Hold |
12,750
| – | – | 0.54% | 54 |
|
|
2020
Q2 | $709K | Hold |
12,750
| – | – | 0.41% | 68 |
|
|
2020
Q1 | $378K | Buy |
+12,750
| New | +$378K | 0.27% | 79 |
|
|
2017
Q3 | – | Sell |
-10,000
| Closed | -$119K | – | 132 |
|
|
2017
Q2 | $119K | Hold |
10,000
| – | – | 0.08% | 124 |
|
|
2017
Q1 | $781K | Buy |
+10,000
| New | +$781K | 0.55% | 56 |
|